Effects of naloxone, glycyrrhizic acid, dexamethasone and deoxycorticosterone in repetitive stress

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 5-6, 1999, Pages 433-437

  Ainsah, O ^a   Nabishah, B M ^a   Osman, C B ^a   Khalid, B A K ^a,b  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Deoxycorticosterone; Dexamethasone; Glycyrrhizic acid; Naloxone; Stress

Indexed keywords

DEOXYCORTICOSTERONE; ENDORPHIN; GLUCOCORTICOID; GLYCYRRHIZIC ACID; MINERALOCORTICOID; NALOXONE; OPIATE;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; IMMOBILIZATION STRESS; INHIBITION KINETICS; LOCOMOTION; MALE; NEGATIVE FEEDBACK; NONHUMAN; RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; DESOXYCORTICOSTERONE; DEXAMETHASONE; ENZYME INHIBITORS; GLUCOCORTICOIDS; GLYCYRRHIZIC ACID; HYDROXYSTEROID DEHYDROGENASES; MALE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; STRESS;

EID: 0033051269     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03052.x     Document Type: Article

References (48)

1. 1. Dijken HHV, Heyden JAMVD, Mos J, Tilders FJH. Inescapable foot-shocks induce progressive and long-lasting behavioural changes in male rats. Physiol. Behav. 1992; 5: 787-94.
2. 2. Curzon G, Kennet GA, Sarna GS, Whitton PS. The effects of tianeptin and other antidepressants on a rat model of depression. Br. J. Psychiatry 1992; 160: 51-5.
3. 3. Armario A, Lopez CA, Jolin T, Castellanos JM. Sensitivity of anterior pituitary hormones to graded levels of psychological stress. Life Sci. 1986; 3: 471-5.
4. 4. Gray TS, Carney ME, Magnuson DJ. Direct projections from the central amygdaloid nucleus: Possible role in stress-induced adrenocorticotrophin release. Neuroendocrinology 1989; 50: 433-46.
5. 5. Eipper BA, Mains RE. Existence of a common precursor to ACTH and endorphin in the anterior and intermediate lobes of the pituitary. J. Supramol. 1978; 8: 247-62.
6. 6. Rivier J, Revier C, Vale W. Interaction of corticotrophin-releasing factor: Effects on ACTH secretion in the rat. Science 1984; 224: 889-91.
7. 7. McIntosh TK, Faden AI. Opiate antagonist in traumatic shock. Ann. Emerg. Med. 1986; 15: 1462-5.
8. 8. Owen PC, Smith R. Opioid peptides in blood and cerebrospinal fluid during acute stress. Clin. Endocrinol. Metab. 1987; 1: 303-8.
9. 9. Lim AT, Khalid BAK, Clements J. Glueocorticoid and mineralocorticoid effects on adrenocorticotrropin and β-endorphin in the adrenalectomised rat. J. Clin. Invest. 1982; 69: 1191-8.
10. 10. Canny BJ, Clarke IJ, Funder JW. Adrenocorticotropin responses to endogenous and exogenous secretagogues in the sheep: Specificity of glucocorticoid action. Hippocampal glucocorticoid receptors and the regulation of ACTH secretion. Neuroendocrinology 1990; 51: 181-9.
11. 11. Nakao K, Oki S, Tanaka I, Nakai Y, Imura H. Concomitant secretion of G MSH with ACTH and β-endorphin in humans. J. Clin. Endocrinol. Metab. 1980; 51: 1205-10.
12. 12. Carr DB, Bullen BA, Skrinar GS et al. Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N. Engl. J. Med. 1981; 305: 560-3.
13. 13. Dubois M, Pickar D, Cohen MR et al. Surgical stress in humans is accompanied by an increase in plasma beta-endorphin-immunoreactivity. Life Sci. 1981; 29: 1249-54.
14. 14. Smith R, Grossman A, Gaillard R et al. Studies on circulating met-enkephalin and β-endorphin: Normal subjects and patients with renal and adrenal disease. Clin. Endocrinol. 1981; 15: 291-5.
15. 15. Rossier J, French ED, Gros C, Minick S, Guillemin R, Bloom FE. Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain. Life Sci. 1977; 25: 2105-12.
16. 16. Faden AI, Holaday JW. Opiate antagonist: A role in the treatment of hypovolemic shock. Science 1979; 205: 317-18.
17. 17. Lim AT, Funder JW. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive ß-endorphin: Effects of diurnal variation, adrenalectomy corticosteroids and opiate agonists and antagonists. Neuroendocrinology 1983; 35: 225-34.
18. 18. Khalid BAK, Paden M, Zainuddin M. The effects of naloxone, dexamethasone, deoxycorticosterone and 17-hydroxyprogesterone on blood pressure responses of normal and adrenalectomized rats during hypovolemic shock. Clin. Exp. Phamacol. Physiol. 1987; 14: 111-17.
19. 19. Nordin M, Morat P, Zainora M. The effect of endogenous opioids on blood pressure during stress. Clin. Exp. Pharmacol Physiol. 1987; 14: 303-8.
20. 20. Yamauchi N, Shibasaki T, Wakabashi I, Demurat H. Brain β-endorphin and other opioids are involved in restraint stress include stimulation of the hypothalamo pituitary-adrenal axis, the sympathetic nervous system and the adrenal medulla in the rat. Brain Res. 1997; 777: 140-6.
21. 21. Krantz DE, Brown WA. Dexamethasone suppresses β-endorphin in humans. Psychoneuroendocrinology 1985; 10: 211-14.
22. 22 Ruzymah BHI, Nabishah BM, Aminuddin S, Khalid BAK. Mineralocorticoid and glycyrrhizic acid block stress induced hypotension in rats. J. Clin. Exp. Hypertens. 1995; 22: 35-9.
23. 23. Mogil JS, Sternberg WF, Balian H, Liebeskind JC, Sadowski B. Opioid and non-opioid swim stress-induced analgesia: A parametric analysis in mice. Physiol. Behav. 1996; 59: 123-32.
24. 24. Canny BJ. Hippocampal glucocorticoid receptors and the regulation of ACTH secretion. Mol. Cell. Endocrinol. 1990; 71: 35-8.
25. 25. Spencer RL, Miller AH, Moday H, Stein M, McEwen BS. Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. Endocrinology 1993; 133: 1941-50.
26. 26. Caudle RM, Mannes AJ, Iadarola MJ. GR89 696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. J. Pharmacol. Exp. Ther. 1997; 283: 1342-9.
27. 27. Bloom F, Segal DS, Ling N. Profound behavioural effects in rat suggest new aetiological factors in mental illness. Science 1976; 194: 630-2.
28. 28. File SE. Naloxone reduces social and exploratory activity in the rat. Psychopharmacology 1980; 71: 41-4.
29. 29. Veldhuis KD, De Kloet ER, Zoest IV, Bohus B. Adrenalectomy reduces exploratory activity in the rat: A specific role of corticosterone. Physiol. Behav. 1982; 16: 191-8.
30. 30. Akao T, Terasawa HS, Kobashi K. Inhibitory effects of glycyrrhetinic acid derivatives on 11β and 3α hydroxysteroid dehydrogenase of rat liver. Chem. Pharm. Bull. 1992; 40: 3021-4.
31. 31. Homma M, Oka K, Ikeshima K et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J. Pharm. Pharmacol. 1995; 47: 687-92.
32. 32. Stewart PM, Whoorwood CB, Mason JIJ. Type 2, 11β-hydroxysteroid dehydrogenase in foetal and adult life. Steroid Biochem. Mol. Biol. 1995; 55: 465-71.
33. 33. Walker BR. Clinical investigation of 11β-hydroxysteroid dehydrogenase. Endocr. Res. 1995; 21: 379-89.
34. 34. Shimojo M, Condon J, Whoorwood CB, Steward PM. 11 beta hydroxysteroid dehydrogenase in the rat adrenal. J. Mol. Endocrinol. 1996; 170: 121-30.
35. 35. Shimojo M, Condon J, Whoorwood CB, Steward PM. Adrenal 11 beta-hydroxysteroid dehydrogenase. Endocr. Res. 1996; 22: 771-80.
36. 36. Seckl JR. IIHSD in the brain: A novel regulator of glucocorticoid action? Front. Neuroendocrinol. 1997; 18: 4-59.
37. 37. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 1989; 125: 1046-53.
38. 38. Monder C, White PC. 11 beta hydroxysteroid dehydrogenase. Vitam Horm. 1993; 47: 187-271.
39. 39. Argawal AK, Mune T, Monder C, White P. NAD 1 dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 1994; 269: 25 959-62.
40. 40. Smith RE, Li KXZ, Andrews RK, Krzowski Z. Immunohistochemical and molecular characterization of the rats 11HSD type 2 enzyme. Endocrinology 1997; 138: 540-7.
41. 41. Whorwood CB, Franklyn JA, Sheppard MC, Stewart PM. Tissue localization of 11β-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J. Steroid. Biochem. Mol. Biol. 1992; 41: 21-8.
42. 42. Moison MP, Seckl JR, Brett LP et al. 11β-Hydroxysteroid dehydrogenase messenger ribonucleic acid expression, bioactivity and immunoreactivity in rat cerebellum. J. Neuroendocrinol. 1990; 2: 853-8.
43. 43. Katz RJ. Animal model of depression: Pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 1982; 16: 965-8.
44. 44. Kennet GA, Dickinson SL, Curzon G. Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res. 1985; 330: 253-63.
45. 45. Koplik EV, Salieva PM, Gorbunnova AV. The open field test as a prognostic criterion of resistance to emotional stress in Wistar rats. Th Vyssh Nerv Deiat Im. Ip Puvlova 1995; 45: 775-81 (Abstract).
46. 46. Haleem DJ. Adaptation to repeated restraint stress to rat: Failure of ethanol-treated rats to adapt in the stress schedule. Alcohol Alcohol. 1996; 31: 471-7.
47. 47. Whitton PS, Sarna GS, Curzon G. Effects of tianeptin on stress induced behavioural deficits and 5-HT dependent behaviour. Psychopharmacology 1991; 104: 81-6.
48. 48. Millan MJ, Przewlocki M, Gramsch VH. Stress-induced release of brain and pituitary β-endorphin: Major role of endorphins in generation of hyperthermia not analgesia. Brain Res. 1981; 208: 325-38.